-65.7%
MRNA vs NTNX
+54.0%
-119.7%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | NTNX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.8% | +4.6% | +5.2% |
| 7D | -1.1% | -3.1% | +2.1% | -0.5% |
| 30D | +126.1% | +2.0% | +124.2% | +124.4% |
| 3M | +190.0% | +34.0% | +156.1% | +171.8% |
| 6M | +157.2% | +72.4% | +84.8% | +126.0% |
| YTD | +388.2% | +27.5% | +360.7% | +356.2% |
| 1Y | +467.0% | -18.7% | +485.8% | +486.4% |
| 3Y | +36.1% | +80.8% | -44.7% | +3.5% |
| All | -65.7% | +54.0% | -119.7% | -75.2% |
Cumulative growth
Daily Returns
Daily percentage return beside NTNX.
Daily Out/Under-Performance
Portfolio return minus NTNX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTNX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded NTNX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling